title: Preoperative intravitreal injection of ranibizumab for patients with severe proliferative diabetic retinopathy contributes to a decreased risk of postoperative neovascular glaucoma.
authors.affiliation: Department of Ophthalmology, First People's Hospital of Shanghai, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
authors.forename: Qianyi
authors.initials: Q
authors.lastname: Lu
authors.affiliation: Department of Ophthalmology, First People's Hospital of Shanghai, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
authors.forename: Chen
authors.initials: C
authors.lastname: Zou
authors.affiliation: Department of Ophthalmology, First People's Hospital of Shanghai, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
authors.forename: Hui
authors.initials: H
authors.lastname: Cao
authors.affiliation: Department of Ophthalmology, First People's Hospital of Shanghai, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
authors.forename: Minjie
authors.initials: M
authors.lastname: Zhao
authors.affiliation: Department of Ophthalmology, First People's Hospital of Shanghai, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
authors.forename: Siqing
authors.initials: S
authors.lastname: Yu
authors.affiliation: Department of Ophthalmology, First People's Hospital of Shanghai, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
authors.forename: Qinghua
authors.initials: Q
authors.lastname: Qiu
authors.affiliation: Department of Ophthalmology, First People's Hospital of Shanghai, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
authors.forename: Xun
authors.initials: X
authors.lastname: Xu
authors.affiliation: Department of Ophthalmology, First People's Hospital of Shanghai, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
authors.forename: Zhi
authors.initials: Z
authors.lastname: Zheng
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D003930:Diabetic Retinopathy / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D015355:Glaucoma, Neovascular / Q000517:prevention & control*; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control*; D000069579:Ranibizumab / Q000627:therapeutic use*; D012189:Retrospective Studies; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity / Q000502:physiology; D014821:Vitrectomy
chemical_list: D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000069579:Ranibizumab